Clinical Trials Directory

Trials / Completed

CompletedNCT05237895

Serum Endocan Levels and Gestational Diabetes

Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Gaziosmanpasa Research and Education Hospital · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Detailed description

It has been shown that endocan level of plasental tissue in gestational diabtes patients is significantly increased when looking at the same week compared with plasenta tissue samples of helathy pregnancy. From the information obtained from these studies, it can be said that there is a strong association between diabetes mellitus and serum endocan levels. investigators aimed to determine the relationship between serum endocan levels and gestational diabetes in the study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSerum Endocan LevelsDetection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Timeline

Start date
2022-03-03
Primary completion
2022-05-05
Completion
2022-05-05
First posted
2022-02-14
Last updated
2022-08-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05237895. Inclusion in this directory is not an endorsement.

Serum Endocan Levels and Gestational Diabetes (NCT05237895) · Clinical Trials Directory